The Impact of China’s Demerit Goods Consumption on Profit Growth in the Pharmaceutical Industry

DOI

10.2991/aebmr.k.220307.269How to use a DOI?

Keywords

Pharmaceutical Industry; Demerit Goods; Economic Crises; Accumulative Sales; Accumulative Profit

Abstract

The pharmaceutical industry is one of the most critical industries for the health and the sustainability of the human race; moreover, the modernized goods can be much more harmful than people expected, which led to severe health problems for humans. The whole experience adopts empirical analysis on the significant number of data of demerit goods and the pharmaceutical industry, so the astonishing results declare that the pharmaceutical industry could have highly relied on the sales of demerit goods. Therefore, the policy advises is that to help the situation of the medical sector, the government should intervene and, when facing any crises, the industry should pay caution on rapid value plunge. The entire study is undoubtedly contributive to give the Chinese example on the relationship of the sales of demerit goods and the profit earned by the pharmaceutical industry, which could help a massive amount of developing countries make the right decisions.

Copyright

© 2022 The Authors. Published by Atlantis Press International B.V.

Open Access

This is an open access article under the CC BY-NC license.

Download article (PDF)

TY  - CONF
AU  - Jiaqi Zhang
PY  - 2022
DA  - 2022/03/26
TI  - The Impact of China’s Demerit Goods Consumption on Profit Growth in the Pharmaceutical Industry
BT  - Proceedings of the 2022 7th International Conference on Financial Innovation and Economic Development (ICFIED 2022)
PB  - Atlantis Press
SP  - 1645
EP  - 1649
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.220307.269
DO  - 10.2991/aebmr.k.220307.269
ID  - Zhang2022
ER  -